Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer

Thomas Horn; Markus Krönke; Isabel Rauscher; Bernhard Haller; Stephanie Robu; Hans Jürgen Wester; Margret Schottelius; Fijs W.B. van Leeuwen; Henk G. van der Poel; Matthias Heck; Jürgen E. Gschwend; Wolfgang Weber; Matthias Eiber; Tobias Maurer

doi:10.1016/j.eururo.2019.03.045

Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer

Thomas Horn
, Markus Krönke
, Isabel Rauscher
, Bernhard Haller
, Stephanie Robu
, Hans Jürgen Wester
, Margret Schottelius
, Fijs W.B. van Leeuwen
, Henk G. van der Poel
, Matthias Heck
, Jürgen E. Gschwend
, Wolfgang Weber
, Matthias Eiber
, Tobias Maurer

Technische Universität München
Leiden University Medical Centre
The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
University Medical Center Hamburg-Eppendorf

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

89 Zitate (Scopus)

Abstract

Prostate-specific membrane antigen (PSMA) radioguided surgery leads to a substantial prostate-specific antigen (PSA) reduction in the vast majority of patients with recurrent prostate cancer. A low PSA value and the presence of only one lesion on preoperative imaging with PSMA-ligand positron emission tomography are prognostic factors for a better outcome.

Originalsprache	Englisch
Seiten (von - bis)	517-523
Seitenumfang	7
Fachzeitschrift	European Urology
Jahrgang	76
Ausgabenummer	4
DOIs	https://doi.org/10.1016/j.eururo.2019.03.045
Publikationsstatus	Veröffentlicht - Okt. 2019

Zugriff auf Dokument

10.1016/j.eururo.2019.03.045

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Fingerprint

Untersuchen Sie die Forschungsthemen von „Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren

Horn, T., Krönke, M., Rauscher, I., Haller, B., Robu, S., Wester, H. J., Schottelius, M., van Leeuwen, F. W. B., van der Poel, H. G., Heck, M., Gschwend, J. E., Weber, W., Eiber, M., & Maurer, T. (2019). Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer. European Urology, 76(4), 517-523. https://doi.org/10.1016/j.eururo.2019.03.045

Horn, Thomas ; Krönke, Markus ; Rauscher, Isabel et al. / Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer. in: European Urology. 2019 ; Jahrgang 76, Nr. 4. S. 517-523.

@article{0eefcc58ff374c678d87a8592ac3854b,

title = "Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer",

abstract = "Prostate-specific membrane antigen (PSMA) radioguided surgery leads to a substantial prostate-specific antigen (PSA) reduction in the vast majority of patients with recurrent prostate cancer. A low PSA value and the presence of only one lesion on preoperative imaging with PSMA-ligand positron emission tomography are prognostic factors for a better outcome.",

keywords = "Biochemical recurrence, Prostate-specific antigen, Prostate-specific membrane antigen, Radioguided surgery, Salvage surgery",

author = "Thomas Horn and Markus Kr{\"o}nke and Isabel Rauscher and Bernhard Haller and Stephanie Robu and Wester, \{Hans J{\"u}rgen\} and Margret Schottelius and \{van Leeuwen\}, \{Fijs W.B.\} and \{van der Poel\}, \{Henk G.\} and Matthias Heck and Gschwend, \{J{\"u}rgen E.\} and Wolfgang Weber and Matthias Eiber and Tobias Maurer",

note = "Publisher Copyright: {\textcopyright} 2019 European Association of Urology",

year = "2019",

month = oct,

doi = "10.1016/j.eururo.2019.03.045",

language = "English",

volume = "76",

pages = "517--523",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "4",

}

Horn, T, Krönke, M, Rauscher, I, Haller, B, Robu, S, Wester, HJ, Schottelius, M, van Leeuwen, FWB, van der Poel, HG, Heck, M, Gschwend, JE , Weber, W , Eiber, M & Maurer, T 2019, 'Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer', European Urology, Jg. 76, Nr. 4, S. 517-523. https://doi.org/10.1016/j.eururo.2019.03.045

Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer. / Horn, Thomas; Krönke, Markus; Rauscher, Isabel et al.
in: European Urology, Jahrgang 76, Nr. 4, 10.2019, S. 517-523.

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

TY - JOUR

T1 - Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer

AU - Horn, Thomas

AU - Krönke, Markus

AU - Rauscher, Isabel

AU - Haller, Bernhard

AU - Robu, Stephanie

AU - Wester, Hans Jürgen

AU - Schottelius, Margret

AU - van Leeuwen, Fijs W.B.

AU - van der Poel, Henk G.

AU - Heck, Matthias

AU - Gschwend, Jürgen E.

AU - Weber, Wolfgang

AU - Eiber, Matthias

AU - Maurer, Tobias

PY - 2019/10

Y1 - 2019/10

N2 - Prostate-specific membrane antigen (PSMA) radioguided surgery leads to a substantial prostate-specific antigen (PSA) reduction in the vast majority of patients with recurrent prostate cancer. A low PSA value and the presence of only one lesion on preoperative imaging with PSMA-ligand positron emission tomography are prognostic factors for a better outcome.

AB - Prostate-specific membrane antigen (PSMA) radioguided surgery leads to a substantial prostate-specific antigen (PSA) reduction in the vast majority of patients with recurrent prostate cancer. A low PSA value and the presence of only one lesion on preoperative imaging with PSMA-ligand positron emission tomography are prognostic factors for a better outcome.

KW - Biochemical recurrence

KW - Prostate-specific antigen

KW - Prostate-specific membrane antigen

KW - Radioguided surgery

KW - Salvage surgery

UR - https://www.scopus.com/pages/publications/85064245148

U2 - 10.1016/j.eururo.2019.03.045

DO - 10.1016/j.eururo.2019.03.045

M3 - Article

C2 - 30987843

AN - SCOPUS:85064245148

SN - 0302-2838

VL - 76

SP - 517

EP - 523

JO - European Urology

JF - European Urology

IS - 4

ER -

Horn T, Krönke M, Rauscher I, Haller B, Robu S, Wester HJ et al. Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer. European Urology. 2019 Okt;76(4):517-523. doi: 10.1016/j.eururo.2019.03.045